Capstone Investment Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-12,708
Closed -$409K – 1923
2026
Q1
$409K Buy
+12,708
New +$470K ﹤0.01% 1229
2025
Q4
– Sell
-9,423
Closed -$323K – 2075
2025
Q3
$323K Sell
9,423
-1,385
-13% -$39.7K ﹤0.01% 1619
2025
Q2
$292K Sell
10,808
-14,792
-58% -$428K ﹤0.01% 1388
2025
Q1
$759K Buy
+25,600
New +$976K ﹤0.01% 963
2024
Q2
– Sell
-13,365
Closed -$296K – 2498
2024
Q1
$296K Buy
+13,365
New +$326K ﹤0.01% 1843

Other funds holding VCYT

Capstone Investment Advisors's VCYT Position: Q2 2026 in Review

Capstone Investment Advisors sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 12,708 shares — an estimated $409K sold.

Capstone Investment Advisors first reported a position in VCYT in Q1 2024 and held it in 5 quarters. The position peaked at $759K in Q1 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Capstone Investment Advisors reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
  • Capstone Investment Advisors sold 12,708 Veracyte shares in Q2 2026, an estimated $409K.
  • Capstone Investment Advisors first reported a position in Veracyte in Q1 2024 and held it in 5 quarters.
  • Capstone Investment Advisors's Veracyte position peaked at $759K in Q1 2025.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.